Search Results - Coupé, Veerle M. H.
- Showing 1 - 20 results of 45
- Go to Next Page
-
1
-
2
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program by Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien
Published 2017Text -
3
-
4
-
5
-
6
-
7
Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation? by Jansen, Femke, Coupé, Veerle M. H., Eerenstein, Simone E. J., Leemans, C. René, Verdonck-de Leeuw, Irma M.
Published 2017Text -
8
-
9
Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care by Bosmans, Judith E., Coupé, Veerle M. H., Knottnerus, Bart J., Geerlings, Suzanne E., Moll van Charante, Eric P., ter Riet, Gerben
Published 2017Text -
10
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening by Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.
Published 2018Text -
11
Efficacy and cost-utility of the eHealth self-management application 'Oncokompas', helping partners of patients with incurable cancer to identify their unmet supportive care needs... by Schuit, Anouk S., Holtmaat, Karen, Hooghiemstra, Nienke, Jansen, Femke, Lissenberg-Witte, Birgit I., Coupé, Veerle M. H., Verdonck-de Leeuw, Irma M.
Published 2020Text -
12
Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non–Small-Cell Lung Cancer by Wolff, Henri B., Alberts, Leonie, Kastelijn, Elisabeth A., El Sharouni, Sherif Y., Schramel, Franz M. N. H., Coupé, Veerle M. H.
Published 2020Text -
13
-
14
-
15
Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients by Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Published 2020Text -
16
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients by Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Published 2021Text -
17
The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care by van der Meijde, Elisabeth, van den Eertwegh, Alfons J. M., Linn, Sabine C., Meijer, Gerrit A., Fijneman, Remond J. A., Coupé, Veerle M. H.
Published 2016Text -
18
The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis by Greuter, Marjolein J E, Berkhof, Johannes, Fijneman, Remond J A, Demirel, Erhan, Lew, Jie-Bin, Meijer, Gerrit A, Stoker, Jaap, Coupé, Veerle M H
Published 2016Text -
19
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data by Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Published 2019Text -
20
Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study by Wolff, Henri B., Alberts, Leonie, Kastelijn, Elisabeth A., Verstegen, Naomi E., El Sharouni, Sherif Y., Schramel, Franz M. N. H., Vos, Rein, Coupé, Veerle M. H.
Published 2021Text